In liver cancer, EIF4A3 has been found to induce dysfunction of CD8+T cells by promoting the formation of circCCAR1, leading to the development of resistance mechanisms against PD-1 inhibitors in tumor cells20. Here, EIF4A3 is linked to neoplasm.